Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 86,038Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Sanofi-Aventis Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2014-04-01

Date Granted : 1997-04-01

Insulin Glargine

Brand Name : LANTUS

Patent Number : 1339044

Filing Date : 1989-09-29

Strength per Unit : 100 IU / ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2014-04-01

Date Granted : 1997-04-01

Sanofi Company Banner

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2014-04-01

Date Granted : 1997-04-01

Insulin Glargine

Brand Name : LANTUS

Patent Number : 1339044

Filing Date : 1989-09-29

Strength per Unit : 100 IU / ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2014-04-01

Date Granted : 1997-04-01

Sanofi Company Banner

03

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2014-04-01

Date Granted : 1997-04-01

Insulin Glargine

Brand Name : LANTUS

Patent Number : 1339044

Filing Date : 1989-09-29

Strength per Unit : 100 U / mL

Dosage Form : Solution (10 mL Vial)

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2014-04-01

Date Granted : 1997-04-01

Sanofi Company Banner

04

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2023-06-05

Date Granted : 2012-07-24

Insulin Glargine

Brand Name : LANTUS

Patent Number : 2490116

Filing Date : 2003-06-05

Strength per Unit : 100 U / mL

Dosage Form : Solution (10 mL Vial)

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2023-06-05

Date Granted : 2012-07-24

Sanofi Company Banner

05

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2014-04-01

Date Granted : 1997-04-01

Insulin Glargine

Brand Name : LANTUS

Patent Number : 1339044

Filing Date : 1989-09-29

Strength per Unit : 100 U / ML

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2014-04-01

Date Granted : 1997-04-01

Sanofi Company Banner

06

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2014-04-01

Date Granted : 1997-04-01

Insulin Glargine

Brand Name : LANTUS

Patent Number : 1339044

Filing Date : 1989-09-29

Strength per Unit : 100 U / mL

Dosage Form : solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2014-04-01

Date Granted : 1997-04-01

Sanofi Company Banner

07

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2031-05-18

Date Granted : 2015-09-29

Insulin Glargine

Brand Name : TOUJEO SOLOSTAR

Patent Number : 2792669

Filing Date : 2011-05-18

Strength per Unit : 300 unit / mL - (450 IU)

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2031-05-18

Date Granted : 2015-09-29

Sanofi Company Banner